A universal homogeneous assay for high-throughput determination of binding kinetics

被引:47
作者
Schiele, Felix [1 ]
Ayaz, Pelin [2 ]
Fernandez-Montalvan, Amaury [1 ]
机构
[1] Bayer HealthCare, Dept Lead Discovery Berlin, Assay Dev High Throughput Screening, D-13353 Berlin, Germany
[2] Bayer HealthCare, Dept Lead Discovery Berlin, Prot Technol, Global Drug Discovery, D-13353 Berlin, Germany
关键词
Binding kinetics; High throughput; Probe competition; TR-FRET; TARGET RESIDENCE TIME; TUMOR-GROWTH INHIBITOR; LIGAND-BINDING; ZK; 304709; BIOCHEMICAL-MECHANISMS; BROMODOMAIN INHIBITORS; DOSE-ESCALATION; PHARMACOKINETICS; RECEPTORS; TOLERABILITY;
D O I
10.1016/j.ab.2014.09.007
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
There is an increasing demand for assay technologies that enable accurate, cost-effective, and high-throughput measurements of drug-target association and dissociation rates. Here we introduce a universal homogeneous kinetic probe competition assay (kPCA) that meets these requirements. The time-resolved fluorescence energy transfer (TR-FRET) procedure combines the versatility of radioligand binding assays with the advantages of homogeneous nonradioactive techniques while approaching the time resolution of surface plasmon resonance (SPR) and related biosensors. We show application of kPCA for three important target classes: enzymes, protein-protein interactions, and G protein-coupled receptors (GPCRs). This method is capable of supporting early stages of drug discovery with large amounts of kinetic information. (C) 2014 Elsevier Inc. All rights reserved.
引用
收藏
页码:42 / 49
页数:8
相关论文
共 36 条
[1]   Targeting cyclin-dependent kinases in anti-neoplastic therapy [J].
Bruyere, Celine ;
Meijer, Laurent .
CURRENT OPINION IN CELL BIOLOGY, 2013, 25 (06) :772-779
[2]  
CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099
[3]   Dual kinase-bromodomain inhibitors for rationally designed polypharmacology [J].
Ciceri, Pietro ;
Mueller, Susanne ;
O'Mahony, Alison ;
Fedorov, Oleg ;
Filippakopoulos, Panagis ;
Hunt, Jeremy P. ;
Lasater, Elisabeth A. ;
Pallares, Gabriel ;
Picaud, Sarah ;
Wells, Christopher ;
Martin, Sarah ;
Wodicka, Lisa M. ;
Shah, Neil P. ;
Treiber, Daniel K. ;
Knapp, Stefan .
NATURE CHEMICAL BIOLOGY, 2014, 10 (04) :305-+
[4]   Opinion - Drug-target residence time and its implications for lead optimization [J].
Copeland, Robert A. ;
Pompliano, David L. ;
Meek, Thomas D. .
NATURE REVIEWS DRUG DISCOVERY, 2006, 5 (09) :730-739
[5]   Pharmacokinetics and the drug-target residence time concept [J].
Dahl, Goran ;
Akerud, Tomas .
DRUG DISCOVERY TODAY, 2013, 18 (15-16) :697-707
[6]   Quantifying the association and dissociation rates of unlabelled antagonists at the muscarinic M3 receptor [J].
Dowling, Mark R. ;
Charlton, Steven J. .
BRITISH JOURNAL OF PHARMACOLOGY, 2006, 148 (07) :927-937
[7]  
Elg M, 1997, THROMB HAEMOSTASIS, V78, P1286
[8]   Selective inhibition of BET bromodomains [J].
Filippakopoulos, Panagis ;
Qi, Jun ;
Picaud, Sarah ;
Shen, Yao ;
Smith, William B. ;
Fedorov, Oleg ;
Morse, Elizabeth M. ;
Keates, Tracey ;
Hickman, Tyler T. ;
Felletar, Ildiko ;
Philpott, Martin ;
Munro, Shonagh ;
McKeown, Michael R. ;
Wang, Yuchuan ;
Christie, Amanda L. ;
West, Nathan ;
Cameron, Michael J. ;
Schwartz, Brian ;
Heightman, Tom D. ;
La Thangue, Nicholas ;
French, Christopher A. ;
Wiest, Olaf ;
Kung, Andrew L. ;
Knapp, Stefan ;
Bradner, James E. .
NATURE, 2010, 468 (7327) :1067-1073
[9]   Binding characteristics of cetirizine and levocetirizine to human H1 histamine receptors:: Contribution of Lys191 and Thr194 [J].
Gillard, M ;
Van Der Perren, C ;
Moguilevsky, N ;
Massingham, R ;
Chatelain, P .
MOLECULAR PHARMACOLOGY, 2002, 61 (02) :391-399
[10]   Open-label, non-randomised, inter-individual dose escalation of ZK 304709 with the evaluation of safety, tolerability, pharmacokinetics, oral bioavailability and orientating efficacy after daily administration in patients with advanced cancer (7 d treatment and 14 d recovery) [J].
Graham, Janet S. ;
Plummer, Ruth ;
McCoy, Candice ;
Kowal, Kristin ;
Wiesinger, Herbert ;
Detjen, Katharina ;
Calvert, Hilary ;
Wiedenmann, Bertram ;
Cassidy, Jim .
EUROPEAN JOURNAL OF CANCER, 2008, 44 (15) :2162-2168